Answers are grounded in this paper and cite their sources.
BACKGROUND/OBJECTIVES: Chronic pancreatitis (CP) is a pathological syndrome of the pancreas characterized by fibrosis and inflammation. At present, there is no definitive cure for CP. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of antidiabetic drugs, have been reported to exert antifibrotic effects in several organs. We evaluated the antifibrotic effect of the SGLT2 inhibitor canagliflozin on the pancreas. METHODS: C57BL/6 mice carrying a Kras mutation were intraperitoneally injected with caerulein to induce CP. Pancreatic tissues were collected after 8 weeks of feeding with or without canagliflozin and subsequently evaluated. The antifibrotic effects were also assessed in human pancreatic stellate cells (HPSCs) and in pancreatic tissue from patients with CP. RESULTS: Canagliflozin preserved pancreatic acinar cells and insulin-positive cells, and reduced pancreatic fibrosis in vivo. In HPSCs, canagliflozin suppressed proliferation, migration, and the expression of fibrotic markers and connective tissue growth factor (CTGF), unlike other SGLT2 inhibitors. A cytokine array was used to investigate the antifibrotic mechanism. Canagliflozin significantly downregulated osteoprotegerin (OPG), leading to the suppression of fibrotic markers and CTGF. Furthermore, canagliflozin activated AMP-activated protein kinase (AMPK), which contributed to the downregulation of OPG. This effect was also observed in pancreatic tissue in vivo by Western blot analysis. In addition, pancreatic tissue from patients with CP contained significantly more OPG-positive cells than did control pancreatic tissue. These results indicate that canagliflozin suppressed pancreatic fibrosis by downregulating OPG. CONCLUSION: Canagliflozin may be an effective therapeutic agent for CP, and our data suggest the AMPK-OPG-CTGF axis is a novel target in CP.
No takes yet. Share an insight, caveat, or question.
Adachi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: